日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dopaminergic modulation of default mode network brain functional connectivity in attention deficit hyperactivity disorder

多巴胺能调节注意力缺陷多动障碍患者的默认模式网络脑功能连接

Silberstein, Richard B; Pipingas, Andrew; Farrow, Maree; Levy, Florence; Stough, Con K

Brain functional connectivity abnormalities in attention-deficit hyperactivity disorder

注意缺陷多动障碍的脑功能连接异常

Silberstein, Richard B; Pipingas, Andrew; Farrow, Maree; Levy, Florence; Stough, Con K; Camfield, David A

Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial

卡瓦治疗广泛性焦虑症(K-GAD):一项随机对照试验的研究方案

Savage, Karen M; Stough, Con K; Byrne, Gerard J; Scholey, Andrew; Bousman, Chad; Murphy, Jenifer; Macdonald, Patricia; Suo, Chao; Hughes, Matthew; Thomas, Stuart; Teschke, Rolf; Xing, Chengguo; Sarris, Jerome

A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the Phospholipid Intervention for Cognitive Ageing Reversal (PLICAR): study protocol for a randomized controlled trial

一项随机对照试验,旨在研究富含磷脂的乳蛋白浓缩物 Lacprodan® PL-20 对老年记忆障碍患者的神经认知影响:磷脂干预逆转认知老化 (PLICAR):一项随机对照试验的研究方案

Scholey, Andrew B; Camfield, David A; Hughes, Matthew E; Woods, Will; K Stough, Con K; White, David J; Gondalia, Shakuntla V; Frederiksen, Pernille D

A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910)

一项随机对照试验研究了碧萝芷和假马齿苋CDRI08草药对认知健康老年人的认知、心血管和生化功能的影响:澳大利亚研究理事会长寿干预(ARCLI)研究方案(ANZCTR12611000487910)

Stough, Con K; Pase, Matthew P; Cropley, Vanessa; Myers, Stephen; Nolidin, Karen; King, Rebecca; Camfield, David; Wesnes, Keith; Pipingas, Andrew; Croft, Kevin; Chang, Dennis; Scholey, Andrew B